|Bid||15.90 x 800|
|Ask||15.91 x 1000|
|Day's Range||15.75 - 16.70|
|52 Week Range||6.46 - 35.67|
|Beta (5Y Monthly)||2.29|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 26, 2024 - Mar 01, 2024|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||26.83|
Subscribe to Yahoo Finance Plus to view Fair Value for TGTX
TG Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, rising from 87 to 93. When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength.
When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...
Fireside chat scheduled for Wednesday, November 29, 2023, at 2:10 PM ETNEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the 6th Annual Evercore ISI HealthCONx Conference, being held at the Kimpton EPIC Hotel, in Miami, Florida on November 28 - 30, 2023. The fireside chat is scheduled to take place on Wednesday, November 29, 2023, at 2:10 PM ET. A live web